Applications Overview

Kinase Inhibitor Drug Discovery & Development Process

The last decade has seen a dramatic increase in the understanding of kinase biology with corresponding investments made in kinase-focused drug discovery. However, despite many successes, the tendency of small molecules to interact with multiple kinases presents both opportunities and challenges for drug discovery. Additionally, more than ever, pharmaceutical organizations are being challenged to maintain innovation, productivity, and tight timelines while continuing to meet the ever growing needs of a globally diverse population in an increasingly resource-constrained and highly competitive environment.  

KINOMEscan provides an integrated suite of kinase screening and selectivity profiling solutions to inform decision making throughout the kinase drug discovery and development process. Our portfolio of services and screening solutions are designed to support the needs of our customers at every stage of development, from high-throughput target screening & small molecule library profiling, to lead optimization and preclinical & clinical development (e.g. off-target profiling to identify potential safety liabilities or reveal new clinical opportunities). Comprehensive KINOMEscan data are a key component required for efficient & successful execution of drug discovery and development programs and enable our partners to extract maximum value from their chemical assets.

Leverage benefits of the industry's largest and highest throughput commercial kinase assay panel and KINOMEscan’s rich combination of kinase expertise and drug discovery experience with the convenience of outsourced high-throughput screening and profiling to expedite your kinase inhibitor discovery program goals.  Click on any of the service icons below to learn more